Food and Drug Administration Broad Agency Announcement (BAA) for the Advanced Research and Development of Regulatory Science - Amendment 2
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- FDABAA-20-00123
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 5417 Scientific Research and Development Services
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration seeks advanced research and development proposals through this Broad Agency Announcement to support regulatory science and innovation across nine key areas. Proposals will undergo a two-tiered review and be evaluated based on technical merit, offeror qualifications, and cost reasonableness, with submissions accepted on a rolling basis through March 2, 2020. The FDA aims to advance scientific knowledge to accomplish its mission of protecting public health.
There is no set-aside designation for this opportunity. Research areas fall under NAICS code 541715 for research and development in the physical, engineering, and life sciences and PSC code R425 for biomedical research and development. Multiple awards of indefinite quantities and values are anticipated, to be conducted within the United States with no maximum or minimum budget ranges specified. Submissions will remain open until further notice as the BAA is renewed annually by the FDA to advance scientific knowledge in support of public health protections.
Notice text
3 versions
Update #3 · Latest ·
Amendment 2
The purpose of this amendment is to: correct the reference in Research Area of Interest 7.3.2. Please see attached document entitled FDABAA-20-00123 - Amendment 2 for the most current version of the FDA's Broad Agency Announcement.
The White Paper due date remains unchanged at March 2, 2020, 5:00pm EST.
Amendment 1
The purpose of this amendment is to: provide the FDA's updated research areas of interest; provide additional information regarding proposal instructions; and, change the White Paper due date from March 13, 2020, to March 2, 2020.
Please see the attached document entitled FDABAA-20-00123 - Amendment 1 for the most current version of the FDA's Broad Agency Announcement.
Original Description
The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation. The FDA anticipates that research and development activities under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation.
*This announcement is a renewal of the FY19 announcement (FDABAA-19-00123) and will remain open until further notice. It is renewed on an annual basis.
Update #2 ·
Amendment 1
The purpose of this amendment is to: provide the FDA's updated research areas of interest; provide additional information regarding proposal instructions; and, change the White Paper due date from March 13, 2020, to March 2, 2020.
Please see the attached document entitled FDABAA-20-00123 - Amendment 1 for the most current version of the FDA's Broad Agency Announcement.
Original Description
The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation. The FDA anticipates that research and development activities under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation.
*This announcement is a renewal of the FY19 announcement (FDABAA-19-00123) and will remain open until further notice. It is renewed on an annual basis.
Update #1 ·
The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation. The FDA anticipates that research and development activities under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation.
*This announcemnet is a renewal of the FY19 announcement (FDABAA-19-00123) and will remain open until further notice. It is renewed on an annual basis.
Files
| File | Type | Posted |
|---|---|---|
| FDABAA-20-00123 - Amendment 2.pdf | ||
| FDABAA-20-00123 - Amendment 1.pdf | ||
| HHS_Small_Business_SubK_Plan.doc | DOC document | |
| FDABAA-20-00123.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Food and Drug Administration Broad Agency Announcement (BAA) for the Advanced Research and Development of Regulatory Science - Amendment 2 | Award Notice | |
| This notice | Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity